Serial Number
98923826
Owner
QUESTEX, LLCAttorney
Deborah J. PeckhamFirst Use Date
Jun 5, 2020
Filing Date
Dec 26, 2024
F FIERCE PHARMA Trademark
Serial Number: 98923826 • Registration: 8074264
Trademark Classes
Class 41 - Education & Entertainment
Education; providing of training; entertainment; sporting and cultural activities
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Correspondence Address
Deborah J. Peckham Barclay Damon LLP
160 Federal Street, Suite 1001
Boston, MA 02110
United States
Trademark Details
Filing Date
December 26, 2024
Registration Date
December 23, 2025
First Use Anywhere
June 5, 2020
First Use in Commerce
June 5, 2020
Published for Opposition
November 4, 2025
Goods & Services
Providing medical and scientific research information and news in the fields of pharmaceuticals, drug development, cell and gene therapy, and drug manufacturing
Conducting, arranging, promoting and organizing trade shows, business expos and buyer events for business purposes in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing public policy information in the field of drugs
Arranging and conducting in-person educational forums, educational meetings, conferences, and conventions in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; educational services, namely, arranging and conducting educational conferences, seminars and workshops in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing information and news in the fields of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations; providing online, non-downloadable newsletters in the fields of pharmaceuticals, drug development, cell and gene therapy, drug manufacturing and drug regulations; conducting of business conferences in the field of pharmaceuticals, drug policy, drug development, cell and gene therapy, drug manufacturing and drug regulations